NCT01649830View on ClinicalTrials.gov

Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma

PHASE3RecruitingINTERVENTIONAL
Enrollment

290

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2026

Conditions
AstrocytomaOligodendrogliomaOligodendroastrocytoma
Interventions
RADIATION

Radiotherapy

External beam radiation: 54.0 Gy in 27 - 30 fractions over 6 - 7 weeks.

DRUG

Temozolomide

dosed at 200 mg/m2 (150 mg/m2 for the first cycle) daily for 5 consecutive days, repeated every 28 days.

Trial Locations (1)

510060

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER